| Trial ID: | L4973 |
| Source ID: | NCT00608179
|
| Associated Drug: |
Glimepiride
|
| Title: |
Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Glimepiride|DRUG: glyburide|OTHER: glucose clamp|OTHER: glucose clamp
|
| Outcome Measures: |
Primary: catecholamines, 1 day |
|
| Sponsor/Collaborators: |
Sponsor: Vanderbilt University
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose:
|
| Start Date: |
2002-08
|
| Completion Date: |
2010-12
|
| Results First Posted: |
|
| Last Update Posted: |
2014-12-11
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00608179
|
